GlassScriptPhysician profile
Shashi Razdan
NPI 1538595913
$2,993.69
in general payments reported to CMS, 2019-2025
20 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $157 · 2021: $201 · 2022: $414 · 2023: $191 · 2024: $706 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $495.78 | 2021-2025 | Rezum Generator, Ams 700, Xpeeda Dsl Fiber |
| Mimedx Group, INC. | $475.68 | 2024-2025 | |
| Coloplast Corp | $293.18 | 2024-2025 | |
| Procept Biorobotics Corporation | $286.07 | 2022-2024 | Aquabeam System |
| Metuchen Pharmaceuticals | $241.84 | 2019-2020 | |
| Axogen | $199.16 | 2025 | |
| Olympus America INC. | $187.31 | 2022 | |
| Profound Medical Corp. | $172.98 | 2025 | Tulsa-Pro |
| Progenics Pharmaceuticals, INC. | $140.87 | 2024 | |
| Biotissue Holdings INC. | $94.13 | 2023 | |
| Intuitive Surgical, INC. | $71.47 | 2021 | |
| Davol INC. | $62.77 | 2022-2023 | Arista Ah Flexitip |
| Telix Pharmaceuticals | $50.38 | 2022-2025 | Illuccix |
| Foundation Medicine, INC. | $46.13 | 2020 | |
| Smith+Nephew, INC. | $40.73 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Civco Medical Instruments | $33.88 | 2024 | |
| Koelis INC. | $31.53 | 2022 | |
| Blue Earth Diagnostics | $26.91 | 2021 | |
| Sumitomo Pharma America, INC. | $25.67 | 2023 | Gemtesa |
| Angiodynamics, INC. | $17.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashi Razdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.